Central Dupage Hospital Cancer Center, Warrenville, Illinois 60555, USA.
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):656-64. doi: 10.1016/j.ijrobp.2013.02.033. Epub 2013 Apr 15.
To assess the impact of prophylactic cranial irradiation (PCI) on self-reported cognitive functioning (SRCF), a functional scale on the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30).
Radiation Therapy Oncology Group (RTOG) protocol 0214 randomized patients with locally advanced non-small cell lung cancer to PCI or observation; RTOG 0212 randomized patients with limited-disease small cell lung cancer to high- or standard-dose PCI. In both trials, Hopkins Verbal Learning Test (HVLT)-Recall and -Delayed Recall and SRCF were assessed at baseline (after locoregional therapy but before PCI or observation) and at 6 and 12 months. Patients developing brain relapse before follow-up evaluation were excluded. Decline was defined using the reliable change index method and correlated with receipt of PCI versus observation using logistic regression modeling. Fisher's exact test correlated decline in SRCF with HVLT decline.
Of the eligible patients pooled from RTOG 0212 and RTOG 0214, 410 (93%) receiving PCI and 173 (96%) undergoing observation completed baseline HVLT or EORTC QLQ-C30 testing and were included in this analysis. Prophylactic cranial irradiation was associated with a higher risk of decline in SRCF at 6 months (odds ratio 3.60, 95% confidence interval 2.34-6.37, P<.0001) and 12 months (odds ratio 3.44, 95% confidence interval 1.84-6.44, P<.0001). Decline on HVLT-Recall at 6 and 12 months was also associated with PCI (P=.002 and P=.002, respectively) but was not closely correlated with decline in SRCF at the same time points (P=.05 and P=.86, respectively).
In lung cancer patients who do not develop brain relapse, PCI is associated with decline in HVLT-tested and self-reported cognitive functioning. Decline in HVLT and decline in SRCF are not closely correlated, suggesting that they may represent distinct elements of the cognitive spectrum.
评估预防性颅脑照射(PCI)对欧洲癌症研究与治疗组织核心生活质量问卷(EORTC QLQ-C30)上自我报告认知功能(SRCF)的影响。
放射治疗肿瘤学组(RTOG)方案 0214 将局部晚期非小细胞肺癌患者随机分为 PCI 组或观察组;RTOG 0212 将局限期小细胞肺癌患者随机分为高剂量或标准剂量 PCI 组。在这两项试验中,在基线(局部区域治疗后但在 PCI 或观察之前)以及 6 个月和 12 个月时,使用霍普金斯词语学习测试(HVLT)-回忆和-延迟回忆以及 SRCF 进行评估。在随访评估前发生脑复发的患者被排除在外。使用可靠变化指数法定义下降,并使用逻辑回归模型与 PCI 与观察组的下降进行相关性分析。Fisher 精确检验分析了 SRCF 与 HVLT 下降的相关性。
从 RTOG 0212 和 RTOG 0214 中筛选出符合条件的患者,410 名(93%)接受 PCI 和 173 名(96%)接受观察组在基线时完成了 HVLT 或 EORTC QLQ-C30 测试,并纳入了本分析。预防性颅脑照射与 6 个月(优势比 3.60,95%置信区间 2.34-6.37,P<.0001)和 12 个月(优势比 3.44,95%置信区间 1.84-6.44,P<.0001)时 SRCF 下降的风险增加相关。6 个月和 12 个月时 HVLT-Recall 的下降也与 PCI 相关(P=.002 和 P=.002),但与同一时间点 SRCF 的下降相关性不大(P=.05 和 P=.86)。
在未发生脑转移的肺癌患者中,PCI 与 HVLT 测试和自我报告认知功能下降相关。HVLT 和 SRCF 的下降并不密切相关,这表明它们可能代表认知谱的不同元素。